ArticleTranslational andrology and urology2026
Efficacy and safety of first-line immunotherapy in advanced renal cell carcinoma: a systematic review and network meta-analysis.
Guanyi Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.